Altimmune, Inc. (ALT)

4.685 -0.18 (-3.80%) USD  |  NASDAQ  |  Feb 09, 16:00
4.70 +0.02 (+0.32%) After-Hours: 07:57
More

Altimmune Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
CorMedix, Inc. Upgrade
Actinium Pharmaceuticals, Inc. Upgrade
Aldeyra Therapeutics, Inc. --
Viking Therapeutics, Inc. --
Seres Therapeutics, Inc. Upgrade